From molecular design to clinical implementation, computational approaches have accelerated and optimized each stage of the development process
PMID: 23259598 Bassi MT, Gasol E, Manzoni M, Pineda M, Riboni M, Martin R, Zorzano A, Borsani G, Palacin M (2001) Identification and characterisation of human xCT that co-expresses, with 4 F2 heavy chain, the amino acid transport activity system x c
Unlike traditional GLP-1 receptor agonists, tirzepatide is more selective for the GIP receptor, resulting in a more balanced activation of these receptors
Biomed Pharmacother 136:111228
It must be considered, however, that mice have a metabolic rate approximately seven times higher than humans, and their experimental tumors display faster doubling times and larger relative weights